Pharming Group NV share price logo

Pharming Group NV

NASDAQ: PHAR

Small Cap

$13.09

+0.47

(+3.69%)

as on

Pharming Group NV Stock Performance

as on May 13, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $12.93
    $13.13
    downward going graph

    1.22%

    Downside

    0.31%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $8.69
    $21.34
    downward going graph

    33.62%

    Downside

    63.03%

    Upside

    downward going graph

Pharming Group NV share price movements today

Previous Close
$12.62
Open
$13.00
Volume
185.3K
Day's Low - High
$12.93 - $13.13
52 Week Low - High
$8.69 - $21.34

Pharming Group NV Historical Returns

1 Month Return
-22.82 %
3 Month Return
-15.11 %
1 Year Return
+ 30.9 %
3 Year Return
+ 18.03 %
5 Year Return
+ 9.91 %

Pharming Group NV Stock Fundamentals & Key Indicators

Check Pharming Group NV market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$891.5M

EPS (TTM)

0.2003

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

1.04%

PE Ratio (TTM)

66.44

Industry PE ratio

-3.7867796610169493

PEG Ratio

0

EBITDA

42.3M

Revenue (TTM)

369.5M

Profit Margin

3.34%

Return On Equity TTM

5.04%

Pharming Group NV Stock Valuation

Track how Pharming Group NV P/E has moved over time to understand its valuation trends.

Pharming Group NV in the last 5 years

  • Overview

  • Trends

Lowest (-179.29x)

March 31, 2025

Industry (-3.79x)

May 13, 2026

Today (66.44x)

May 13, 2026

Highest (154.11x)

March 31, 2026

LowHigh

Today’s Price to Earnings Ratio: 66.44x

Pharming Group NV vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Pharming Group NV with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$891.5M9.91%66.443.34%
BUY$38.0B119.7%71.3912.55%
NA$32.7BNA71.448.94%
BUY$110.4B109.14%25.8435.51%
BUY$74.7B39.88%17.3929.65%

Stock Returns calculator for Pharming Group NV Stock including INR - Dollar returns

The Pharming Group NV stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Pharming Group NV investment value today

Current value as on today

₹1,46,911

Returns

₹46,911

(+46.91%)

Returns from Pharming Group NV Stock

₹30,900 (+30.9%)

Dollar Impact

₹16,011 (+16.01%)

Analyst Recommendation on Pharming Group NV Stock

Based on 14 analysts

BUY

92.86%

Buy

7.14%

Hold

0.00%

Sell

Based on 14 analysts, 92.86% of analysts recommend a 'BUY' rating for Pharming Group NV. Average target price of $34.35

Pharming Group NV Share Price Target

Get share price movements and forecasts by analysts on Pharming Group NV.

What analysts predicted

61.89%UPSIDE

Target Price

$34.35

Current Price

$13.09

Analyzed by

14 Analysts

Target

$34.35

Pharming Group NV target price $34.35, a slight upside of 61.89% compared to current price of $13.09. According to 14 analysts rating.

Indian Investors' Interest in Pharming Group NV Stock

Search interest for Pharming Group NV Stock has increased by 96% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:96% versus previous 30 day period

Pharming Group NV Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
81
55
74
74
92,700
79
93
97
106,500
72
Gross Profit
74
47
66
68
80,500
70
84
90
85,400
66
Operating Income
0
-16
-3
4
6,600
-7
10
15
2,000
2
EBITDA
8
-9
-4
7
-
-4
9
23
6,203
5
Interest Expense
4
1
1
2
-
5
0
7
1,400
2
Depreciation
7
5
0
2
7
2
2
2
3
-
Income Before Tax
-2
-16
0
1
6,700
-11
7
12
4,800
-4
Income Tax Expense
0
-4
1
2
-
3
2
5
-500
0
Net Income
-2
-12
-1
-1
2,900
-14
4
7
5,300
-5
Net Profit Margin
-3.33%
-22.39%
-1.62%
-1.38%
3.13%
-18.61%
5.04%
7.76%
4.98%
-7.20%

Pharming Group NV Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
16
107
154
189
212
198
205
245
297
377
Gross Profit
11
92
129
165
188
177
188
220
261
331
Operating Income
-12
26
43
68
76
13
18
-5
-8
19
EBITDA
-13
-39
50
71
58
48
33
9
16
30
Interest Expense
3
21
16
13
10
6
5
5
8
21
Depreciation
-
3
6
5
7
16
13
15
16
11
Income Before Tax
-18
-107
0
52
44
23
14
-12
-8
12
Income Tax Expense
3
-11
-27
11
6
7
1
-1
3
10
Net Income
-18
-95
28
40
37
15
13
-10
-11
2
Net Profit Margin
-110.48%
-89.22%
18.50%
21.41%
17.79%
8.04%
6.65%
-4.30%
-3.98%
0.76%

Pharming Group NV Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-16
-1
-1
3
-11
7
7
5
-5
Operating Cash Flow
-7
-13
9
9
0
11
30
7
1
Investing Cash Flow
0
36
4
-
9
16
-2
0
-85
Financing Cash Flow
-2
-28
-1
-2
-6
-2
11
3
-9
Change in Cash
-9
-4
13
-2
5
31
38
13
-92

Pharming Group NV Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
26
43
52
44
23
14
-12
-8
2
Operating Cash Flow
45
46
74
83
37
22
-17
-1
50
Investing Cash Flow
-7
-4
-28
-15
-21
5
-129
31
18
Financing Cash Flow
-3
-20
-63
60
-27
-4
-1
-34
14
Change in Cash
33
24
-17
130
-13
15
-145
-6
91

Global Institutional Holdings in Pharming Group NV

Funds
Holdings
Bessemer Group Inc
0%
Millennium Management LLC
0.03%
Coldstream Capital Management Inc
0%
Citadel Advisors Llc
0.03%
SmartHarvest Portfolios, LLC
0.02%

Insights on Pharming Group NV

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, BeOne Medicines Ltd has given 40.2% return, outperforming this stock by 9.3%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 32.2% return, outperforming this stock by 14.2%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 106.5B → 72.71M (in $), with an average decrease of 99.9% per quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 5.3B → -5.23M (in $), with an average decrease of 100.1% per quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, PHAR stock has moved down by -20.2%

About Pharming Group NV

Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company's lead product is RUCONEST, a recombinant C1 esterase inhibitor for the treatment of acute attacks in adult and adolescent patients with acute hereditary angioedema (HAE); and Joenja (leniolisib), an oral small molecule PI3K" inhibitor for the treatment of activated phosphoinositide 3-kinase delta syndrome. It also develops Joenja, an oral small molecule PI3K" inhibitor. It has a development collaboration and license agreement with Novartis. Pharming Group N.V. was incorporated in 1988 and is headquartered in Leiden, the Netherlands.
OrganisationPharming Group NV
HeadquartersDarwinweg 24, Leiden, Netherlands, 2333 CR
IndustryBiotechnology
CEOMr. Fabrice Chouraqui Ph.D., Pharm.D.
E-voting on sharesClick here to vote

Key Management of Pharming Group NV

Name

Title

Dr. Alexander Breidenbach M.B.A.

Chief Business Officer

Ms. Leverne Marsh

Chief Commercial Officer

Mr. Fabrice Chouraqui Ph.D., Pharm.D.

CEO & Executive Director

Ms. Mireille Sanders M.Sc.

Chief Operations Officer

Mr. Ruud Van Outersterp

Chief Legal & Compliance Officer

Dr. Anurag Relan M.D., MPH

Chief Medical Officer

Dr. Magnus Hansson

Medical Director

Mr. Kenneth Lynard EMBA

Chief Financial Officer

Mr. Michael K. Levitan

VP of Investor Relations & Corporate Communications

Ms. Ines Bernal

Chief People Officer

FAQs

What is Pharming Group NV share price today?

Pharming Group NV share price today is $13.09 as on at the close of the market. Pharming Group NV share today touched a day high of $13.13 and a low of $12.93.

What is the 52 week high and 52 week low for Pharming Group NV share?

Pharming Group NV share touched a 52 week high of $21.34 on and a 52 week low of $8.69 on . Pharming Group NV stock price today i.e. is closed at $13.09,which is 38.66% down from its 52 week high and 50.66% up from its 52 week low.

What is Pharming Group NV's market capitalisation today?

Pharming Group NV market capitalisation is $0.00T as on .

How to invest in Pharming Group NV Stock (PHAR) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Pharming Group NV on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Pharming Group NV Shares that will get you 0.1146 shares as per Pharming Group NV share price of $13.09 per share as on May 13, 2026 at 8:45 am IST.

What is the minimum amount required to buy Pharming Group NV Stock (PHAR) from India?

Indian investors can start investing in Pharming Group NV (PHAR) shares with as little as ₹95.705 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹957.05 in Pharming Group NV stock (as per the Rupee-Dollar exchange rate as on ). Based on Pharming Group NV share’s latest price of $13.09 as on May 13, 2026 at 8:45 am IST, you will get 0.7639 shares of Pharming Group NV. Learn more about fractional shares .

What are the returns that Pharming Group NV has given to Indian investors in the last 5 years?

Pharming Group NV stock has given 9.91% share price returns and 29.72% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?